![Jens M. Kelm](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Jens M. Kelm
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
InSphero AG
![]() InSphero AG BiotechnologyHealth Technology InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland. | Presidente | 26/03/2009 | - |
Director Técnico/Científico/I+D | 17/06/2013 | - | |
Fundador | 26/03/2009 | - | |
PreComb Therapeutics AG
![]() PreComb Therapeutics AG Pharmaceuticals: MajorHealth Technology PreComb Therapeutics AG is a Swiss company that specializes in functional precision medicine for oncology and cancer. The company is based in Hombrechtikon, Switzerland. The company uses organoid and predictive technologies, as well as AI and data mining, to guide therapy and automate processes. The company also works in immune oncology and collaborate with other organizations such as 2curex, Xilis, USZ, DKFZ, and NCT. The company was founded in 2018 by Peter Steiner and Jens M. Kelm, with Jens M. Kelm serving as CEO since then. | Director Ejecutivo | - | - |
Fundador | 01/01/2018 | - |
Historial de carrera de Jens M. Kelm
Antiguos cargos conocidos de Jens M. Kelm.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
University of Zurich | Corporate Officer/Principal | 01/12/2009 | 01/12/2009 |
Estadísticas
Internacional
Suiza | 4 |
Operativa
Founder | 2 |
Chairman | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
InSphero AG
![]() InSphero AG BiotechnologyHealth Technology InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland. | Health Technology |
PreComb Therapeutics AG
![]() PreComb Therapeutics AG Pharmaceuticals: MajorHealth Technology PreComb Therapeutics AG is a Swiss company that specializes in functional precision medicine for oncology and cancer. The company is based in Hombrechtikon, Switzerland. The company uses organoid and predictive technologies, as well as AI and data mining, to guide therapy and automate processes. The company also works in immune oncology and collaborate with other organizations such as 2curex, Xilis, USZ, DKFZ, and NCT. The company was founded in 2018 by Peter Steiner and Jens M. Kelm, with Jens M. Kelm serving as CEO since then. | Health Technology |
- Bolsa de valores
- Insiders
- Jens M. Kelm
- Experiencia